References
Feb 25, 1999·The New England Journal of Medicine·N C Andreasen
Mar 17, 1999·Archives of General Psychiatry·D RobinsonJ A Lieberman
Mar 3, 2004·The American Journal of Psychiatry·Christoph U CorrellJohn M Kane
Jan 12, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Anissa Abi-Dargham, Marc Laruelle
Jan 5, 2011·Journal of Clinical Epidemiology·Gordon GuyattHolger J Schünemann
Jul 26, 2011·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Aug 2, 2011·Journal of Clinical Epidemiology·Gordon H GuyattHolger J Schünemann
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Mar 30, 2012·PloS One·James B KirkbridePeter B Jones
Mar 22, 2014·International Journal of Epidemiology·Zachary SteelDerrick Silove
Jun 21, 2014·The Journal of Pharmacology and Experimental Therapeutics·Kenji MaedaTetsuro Kikuchi
Sep 17, 2014·The Journal of Pharmacology and Experimental Therapeutics·Chris A OosterhofPierre Blier
Feb 16, 2015·Schizophrenia Research·John M KaneHans Eriksson
Feb 18, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tamaki IshimaKenji Hashimoto
Apr 18, 2015·The American Journal of Psychiatry·Christoph U CorrellHans Eriksson
Aug 8, 2015·International Journal of Clinical Practice·L Citrome
Aug 25, 2015·The Journal of Clinical Psychiatry·Michael E ThaseHans Eriksson
Aug 25, 2015·The Journal of Clinical Psychiatry·Michael E ThaseHans Eriksson
Mar 11, 2016·International Clinical Psychopharmacology·Leslie CitromeRoss A Baker
May 24, 2016·Schizophrenia Research·Mamta SapraAnjali Varma
May 28, 2016·Expert Opinion on Investigational Drugs·Ricardo P GarayPierre-Michel Llorca
Jul 6, 2016·The Journal of Clinical Psychiatry·Maurizio FavaRoss A Baker
Oct 27, 2016·Brain and Behavior·Lori L DavisRoss A Baker
Nov 16, 2016·Psychopharmacology·Min MaKenji Hashimoto
Jan 31, 2017·Archives of Gerontology and Geriatrics·Henry C Ndukwe, Prasad S Nishtala
Mar 24, 2017·Therapeutics and Clinical Risk Management·Nishant B ParikhAnita H Clayton
Jul 28, 2017·Journal of Clinical Pharmacology·Jun IshigookaYoshihiro Tadori
Nov 13, 2017·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hanna E van den MunkhofFrancesc Artigas
Dec 12, 2017·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hagit CohenJørn Arnt
Jan 19, 2018·Current Medical Research and Opinion·Mary HobartRobert D McQuade
Feb 11, 2018·Perspectives in Psychiatric Care·Traci AladeenRoger S McIntyre
May 19, 2018·Psychiatry and Clinical Neurosciences·Jun IshigookaYoshihiro Tadori
Jun 5, 2018·Annals of Translational Medicine·Wilbert S Aronow, Tatyana A Shamliyan
Jul 25, 2018·International Journal of Geriatric Psychiatry·Ulla LepolaMary Hobart
Jan 9, 2019·Clinical Therapeutics·Michael S BroderIrina Yermilov
Jan 24, 2019·Drugs·James E Frampton
Jan 31, 2019·Neuropsychiatric Disease and Treatment·Kristen Ward, Leslie Citrome
Feb 26, 2019·Journal of Affective Disorders·E Sherwood BrownChastity Escalante
Apr 5, 2019·Journal of Clinical Psychopharmacology·Mary HobartRobert D McQuade
May 9, 2019·Pharmacology·Keisuke ObaraYoshio Tanaka
Jul 1, 2019·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Filippo CorponiAlessandro Serretti
Jul 11, 2019·Psychiatria Danubina·Ayman Antoun Reyad, Raafat Mishriky
Jul 28, 2019·The International Journal of Neuropsychopharmacology·Taro KishiNakao Iwata
Aug 23, 2019·Expert Opinion on Pharmacotherapy·Michele FornaroDomenico De Berardis
Sep 6, 2019·Neuropsychopharmacology Reports·Naoki AmadaTakashi Futamura
Sep 29, 2019·Chemical Research in Toxicology·Bingbing ChenGuo-Xin Hu